Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults. β
Go to Publication β
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 82 Issue 19 Pages: 5850-9 Pub: 2016 Oct 1 Epub: 2016 Sep 16 Authors Gargari G , Taverniti V , Balzaretti S , Ferrario C , Gardana C , Simonetti P , Guglielmetti S , |
|
|
Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults. β
Go to Publication β
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 82 Issue 19 Pages: 5850-9 Pub: 2016 Oct 1 Epub: 2016 Sep 16 Authors Gargari G , Taverniti V , Balzaretti S , Ferrario C , Gardana C , Simonetti P , Guglielmetti S , |
|
|
Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults. β
Go to Publication β
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 82 Issue 19 Pages: 5850-9 Pub: 2016 Oct 1 Epub: 2016 Sep 16 Authors Gargari G , Taverniti V , Balzaretti S , Ferrario C , Gardana C , Simonetti P , Guglielmetti S , |
|
|
Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults. β
Go to Publication β
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 82 Issue 19 Pages: 5850-9 Pub: 2016 Oct 1 Epub: 2016 Sep 16 Authors Gargari G , Taverniti V , Balzaretti S , Ferrario C , Gardana C , Simonetti P , Guglielmetti S , |
|
|
Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults. β
Go to Publication β
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 82 Issue 19 Pages: 5850-9 Pub: 2016 Oct 1 Epub: 2016 Sep 16 Authors Gargari G , Taverniti V , Balzaretti S , Ferrario C , Gardana C , Simonetti P , Guglielmetti S , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , |
|
|
Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. β
Go to Publication β
Journal of food biochemistry (J Food Biochem ) Vol: 44 Issue 11 Pages: e13489 Pub: 2020 Nov Epub: 2020 Sep 29 Authors Jing W , Liu Q , Wang W , |
|
|
Effect of Bifidobacterium bifidum G9-1 on the Intestinal Environment and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-like Symptoms in Patients with Quiescent Crohn`s Disease: A Prospective Pilot Study. β
Go to Publication β
Journal of clinical medicine (J Clin Med ) Vol: 12 Issue 10 Pages: Pub: 2023 May 9 Epub: 2023 May 9 Authors Tomita T , Fukui H , Okugawa T , Nakanishi T , Mieno M , Nakai K , Eda H , Kitayama Y , Oshima T , Shinzaki S , Miwa H , |
|
|
Investigating the antimicrobial and anti-inflammatory effects of Lactobacillus and Bifidobacterium spp. on cariogenic and periodontitis pathogens. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1383959 Pub: 2024 Epub: 2024 May 30 Authors Mahdizade Ari M , Mirkalantari S , Darban-Sarokhalil D , Darbandi A , Razavi S , Talebi M , |
|
|
Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating Microbial Metabolome and Targeting Gut Microbiota. β
Go to Publication β
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: Issue Pages: Pub: 2024 Jun 5 Epub: 2024 Jun 5 Authors Han M , Liang J , Hou M , Liu Y , Li H , Gao Z , |
|
|
Bifidobacterium bifidum and Lactobacillus paracasei alleviate sarcopenia and cognitive impairment in aged mice by regulating gut microbiota-mediated AKT, NF-?B, and FOXO3a signaling pathways. β
Go to Publication β
Immunity & ageing : I & A (Immun Ageing ) Vol: 20 Issue 1 Pages: 56 Pub: 2023 Oct 23 Epub: 2023 Oct 23 Authors Baek JS , Shin YJ , Ma X , Park HS , Hwang YH , Kim DH , |
|
|
Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 24 Pages: Pub: 2022 Dec 8 Epub: 2022 Dec 8 Authors Feng C , Zhang W , Zhang T , He Q , Kwok LY , Tan Y , Zhang H , |
|
|
Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 24 Pages: Pub: 2022 Dec 8 Epub: 2022 Dec 8 Authors Feng C , Zhang W , Zhang T , He Q , Kwok LY , Tan Y , Zhang H , |
|
|
Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 24 Pages: Pub: 2022 Dec 8 Epub: 2022 Dec 8 Authors Feng C , Zhang W , Zhang T , He Q , Kwok LY , Tan Y , Zhang H , |
|
|
Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 24 Pages: Pub: 2022 Dec 8 Epub: 2022 Dec 8 Authors Feng C , Zhang W , Zhang T , He Q , Kwok LY , Tan Y , Zhang H , |
|
|
Lactobacillus plantarum and Bifidobacterium bifidum alleviate dry eye in mice with exorbital lacrimal gland excision by modulating gut inflammation and microbiota. β
Go to Publication β
Food & function (Food Funct ) Vol: 12 Issue 6 Pages: 2489-2497 Pub: 2021 Mar 21 Epub: 2021 Mar 3 Authors Yun SW , Son YH , Lee DY , Shin YJ , Han MJ , Kim DH , |
|
|
Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice. β
Go to Publication β
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 13 Pages: 5915-5928 Pub: 2020 Jul Epub: 2020 May 4 Authors Wang Q , Wang K , Wu W , Lv L , Bian X , Yang L , Wang Q , Li Y , Ye J , Fang D , Wu J , Jiang X , Xie J , Lu Y , Li L , |
|
|
Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice. β
Go to Publication β
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 13 Pages: 5915-5928 Pub: 2020 Jul Epub: 2020 May 4 Authors Wang Q , Wang K , Wu W , Lv L , Bian X , Yang L , Wang Q , Li Y , Ye J , Fang D , Wu J , Jiang X , Xie J , Lu Y , Li L , |
|
|
Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice. β
Go to Publication β
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 13 Pages: 5915-5928 Pub: 2020 Jul Epub: 2020 May 4 Authors Wang Q , Wang K , Wu W , Lv L , Bian X , Yang L , Wang Q , Li Y , Ye J , Fang D , Wu J , Jiang X , Xie J , Lu Y , Li L , |
|
|
Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora. β
World journal of microbiology & biotechnology (World J Microbiol Biotechnol ) Vol: 30 Issue 3 Pages: 847-53 Pub: 2014 Mar Epub: Authors Wang YH , Huang Y , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
